MARC details
| 000 -LEADER |
|---|
| fixed length control field |
04882cam a2200553Ii 4500 |
| 001 - CONTROL NUMBER |
|---|
| control field |
ocn991595808 |
| 003 - CONTROL NUMBER IDENTIFIER |
|---|
| control field |
OCoLC |
| 005 - DATE AND TIME OF LATEST TRANSACTION |
|---|
| control field |
20220712055129.0 |
| 006 - FIXED-LENGTH DATA ELEMENTS--ADDITIONAL MATERIAL CHARACTERISTICS--GENERAL INFORMATION |
|---|
| fixed length control field |
m o d |
| 007 - PHYSICAL DESCRIPTION FIXED FIELD--GENERAL INFORMATION |
|---|
| fixed length control field |
cr cnu|||unuuu |
| 008 - FIXED-LENGTH DATA ELEMENTS--GENERAL INFORMATION |
|---|
| fixed length control field |
170626s2017 nyu ob 001 0 eng d |
| 040 ## - CATALOGING SOURCE |
|---|
| Original cataloging agency |
N$T |
| Language of cataloging |
eng |
| Description conventions |
rda |
| -- |
pn |
| Transcribing agency |
N$T |
| Modifying agency |
N$T |
| -- |
EBLCP |
| -- |
OCLCF |
| -- |
AGLDB |
| -- |
IGB |
| -- |
AUW |
| -- |
BTN |
| -- |
MHW |
| -- |
INTCL |
| -- |
SNK |
| -- |
YDX |
| -- |
G3B |
| -- |
S8I |
| -- |
S8J |
| -- |
STF |
| -- |
D6H |
| -- |
N$T |
| -- |
OCLCQ |
| -- |
OCLCO |
| 020 ## - INTERNATIONAL STANDARD BOOK NUMBER |
|---|
| International Standard Book Number |
9781536119589 |
| Qualifying information |
(electronic bk.) |
| 020 ## - INTERNATIONAL STANDARD BOOK NUMBER |
|---|
| International Standard Book Number |
153611958X |
| Qualifying information |
(electronic bk.) |
| 020 ## - INTERNATIONAL STANDARD BOOK NUMBER |
|---|
| Cancelled/invalid ISBN |
9781536119381 |
| 035 ## - SYSTEM CONTROL NUMBER |
|---|
| System control number |
(OCoLC)991595808 |
| 050 #4 - LIBRARY OF CONGRESS CALL NUMBER |
|---|
| Classification number |
RM315 |
| 072 #7 - SUBJECT CATEGORY CODE |
|---|
| Subject category code |
MED |
| Subject category code subdivision |
105020 |
| Source |
bisacsh |
| 082 04 - DEWEY DECIMAL CLASSIFICATION NUMBER |
|---|
| Classification number |
615.788 |
| Edition number |
23 |
| 049 ## - LOCAL HOLDINGS (OCLC) |
|---|
| Holding library |
MAIN |
| 245 00 - TITLE STATEMENT |
|---|
| Title |
Psychotropic drugs and medical conditions / |
| Statement of responsibility, etc |
Faruk Uguz, editor. |
| 264 #1 - |
|---|
| -- |
New York : |
| -- |
Nova Biomedical, |
| -- |
[2017] |
| 300 ## - PHYSICAL DESCRIPTION |
|---|
| Extent |
1 online resource |
| 336 ## - |
|---|
| -- |
text |
| -- |
txt |
| -- |
rdacontent |
| 337 ## - |
|---|
| -- |
computer |
| -- |
c |
| -- |
rdamedia |
| 338 ## - |
|---|
| -- |
online resource |
| -- |
cr |
| -- |
rdacarrier |
| 490 1# - SERIES STATEMENT |
|---|
| Series statement |
Psychiatry, theory, applications and treatments |
| 504 ## - BIBLIOGRAPHY, ETC. NOTE |
|---|
| Bibliography, etc |
Includes bibliographical references and index. |
| 588 0# - |
|---|
| -- |
Online resource; title from PDF title page (EBSCO, viewed June 27, 2017) |
| 505 0# - FORMATTED CONTENTS NOTE |
|---|
| Formatted contents note |
Preface; Acknowledgments; Chapter 1; Hematological Effects of Psychotropic Medications; Abstract; Introduction; Antipsychotic Medications; Second Generation Antipsychotic Drugs; Clozapine; Olanzapine; Risperidone and Paliperidone: Short-Acting and Long-Acting; Quetiapine; Ziprasidone; Aripiprazole; Iloperidone, Asenapine, and Lurasidone; First Generation Antipsychotic Drugs; Phenothiazines; Butyrophenones; Mood Stabilizer Medications; Carbamazepine; Oxcarbazepine; Divalproex; Lamotrigine; Lithium; Gabapentin; Pregabalin; Topiramate; Antidepressant Drugs |
| 505 8# - FORMATTED CONTENTS NOTE |
|---|
| Formatted contents note |
Selective Serotonin Reuptake InhibitorsBupropion; Selective Serotonin Norepinephrine Reuptake Inhibitors; Atypical Antidepressants; Tricyclic and Tetracyclic Antidepressants; Benzodiazepines; Buspirone; Management; Conclusion; References; Chapter 2; Psychotropic Drug-Induced Renal Toxicity and Electrolyte Imbalance; Abstract; Introduction; Role of Kidneys in Drug Metabolism and Homeostasis; Psychotropics Known to Cause Renal Impairment and Electrolyte Imbalance; Psychotropics Causing Renal Toxicity; Lithium; Reduced Urinary Concentrating Capacity; Effect on Glomerular Filtration Rate |
| 505 8# - FORMATTED CONTENTS NOTE |
|---|
| Formatted contents note |
Development of Nephrogenic Diabetes Insipidus (NDI)Other Renal Effects of Lithium; Antidepressants; Antipsychotics; Psychotropics Causing Electrolyte Imbalance; Psychotropic-Induced Hyponatremia (Table 3); Antidepressants; Antipsychotics; Mood Stabilizers; Psychotropic-Induced Hypernatremia (Table 4); Psychotropic-Induced Hypokalemia (Table 4); Antidepressants; Antipsychotics; Mood Stabilizers; Psychotropic-Induced Hyperkalemia (Table 4); Psychotropic-Induced Hypocalcemia (Table 4); Psychotropic-Induced Hypercalcemia (Table 4) |
| 505 8# - FORMATTED CONTENTS NOTE |
|---|
| Formatted contents note |
Risk Factors of Psychotropic Induced Renal Impairment and Electrolyte ImbalanceAge; Gender; Physical Health and Co-Morbid Physical Illness; History of Hyponatremia/Electrolyte Disturbances in the Past; Nature of Psychiatry Disorder; Use of Other Concomitant Medications; Dose of Psychotropic Drug Used; Duration of Treatment; How to Prevent?; Psychotropic-Induced Renal Impairment; Psychotropic-induced Electrolyte Imbalance; Management; Management of Psychotropic-induced Renal Impairment Due to Rhabdomyolysis; Management of Lithium-induced Nephrogenic Diabetes Insipidus (NDI) |
| 505 8# - FORMATTED CONTENTS NOTE |
|---|
| Formatted contents note |
Management of Lithium-Induced NephropathyTreatment of Lithium Toxicity and When to Go for Dialysis?; Psychotropic-Induced Electrolyte Imbalances; Hyponatremia; Management of Other Psychotropic-induced Electrolyte Imbalances; Conclusion; References; Chapter 3; Psychotropic Drug-Induced Hepatotoxicity; Abstract; Introduction; Antidepressants; Monoamine Oxidase (MAO) Inhibitors; Tricyclic Antidepressants; Selective Serotonin Reuptake Inhibitors; Serotonin Noradrenaline Reuptake Inhibitors; New Generation Antidepressants; Antipsychotic Agents; First Generation Antipsychotics (FGAs) |
| 590 ## - LOCAL NOTE (RLIN) |
|---|
| Local note |
eBooks on EBSCOhost |
| Provenance (VM) [OBSOLETE] |
EBSCO eBook Subscription Academic Collection - Worldwide |
| 650 #0 - SUBJECT ADDED ENTRY--TOPICAL TERM |
|---|
| Topical term or geographic name as entry element |
Psychotropic drugs. |
| 9 (RLIN) |
145490 |
| 650 #2 - SUBJECT ADDED ENTRY--TOPICAL TERM |
|---|
| Topical term or geographic name as entry element |
Psychotropic Drugs |
| 9 (RLIN) |
145490 |
| 650 #6 - SUBJECT ADDED ENTRY--TOPICAL TERM |
|---|
| Topical term or geographic name as entry element |
Psychotropes. |
| 650 #7 - SUBJECT ADDED ENTRY--TOPICAL TERM |
|---|
| Topical term or geographic name as entry element |
MEDICAL |
| General subdivision |
Psychiatry |
| -- |
Psychopharmacology. |
| Source of heading or term |
bisacsh |
| 9 (RLIN) |
883258 |
| 650 #7 - SUBJECT ADDED ENTRY--TOPICAL TERM |
|---|
| Topical term or geographic name as entry element |
Psychotropic drugs. |
| Source of heading or term |
fast |
| -- |
(OCoLC)fst01081826 |
| 9 (RLIN) |
145490 |
| 655 #4 - INDEX TERM--GENRE/FORM |
|---|
| Genre/form data or focus term |
Electronic books. |
| 700 1# - ADDED ENTRY--PERSONAL NAME |
|---|
| Personal name |
Uguz, Faruk, |
| Relator term |
editor. |
| 9 (RLIN) |
1094525 |
| 830 #0 - SERIES ADDED ENTRY--UNIFORM TITLE |
|---|
| Uniform title |
Psychiatry- theory, applications, and treatments series. |
| 9 (RLIN) |
868676 |
| 856 40 - ELECTRONIC LOCATION AND ACCESS |
|---|
| Uniform Resource Identifier |
<a href="https://search.ebscohost.com/login.aspx?direct=true&scope=site&db=nlebk&AN=1540037">https://search.ebscohost.com/login.aspx?direct=true&scope=site&db=nlebk&AN=1540037</a> |
| 938 ## - |
|---|
| -- |
ProQuest Ebook Central |
| -- |
EBLB |
| -- |
EBL4882736 |
| 938 ## - |
|---|
| -- |
EBSCOhost |
| -- |
EBSC |
| -- |
1540037 |
| 938 ## - |
|---|
| -- |
YBP Library Services |
| -- |
YANK |
| -- |
14263210 |
| 994 ## - |
|---|
| -- |
92 |
| -- |
INOPJ |
